Clinical Trial Update: Conservative Pulp Therapy of Primary Molars Using TheraCAL [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Conservative Pulp Therapy of primary molars using Theracal for reversible pulpitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Reversible Pulpitis

Drugs mentioned

• Theracal (Theracal LC)

Snippet

Sponsor: Ain Shams University | Conditions: Reversible Pulpitis | Phase 3 | Status: COMPLETED